National Mergers and Acquisitions company, ProNova Partners, announces a consultation agreement to assist in the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group
LOS ANGELES, Calif., June 2, 2022 (SEND2PRESS NEWSWIRE) – Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.
“This venture capital investment partnership was founded in 2018,” announced Rick Carlson, CEO of ProNova Partners. “On behalf of their members, they find and invest in game changing, cutting edge, emerging companies specializing in Artificial Intelligence Radiology Imaging and other Medical Technologies.”
“The group is owned and operated by three managing partners with broad ranging domain expertise,” continued Carlson. “We are very pleased to work with such a qualified group. They are finding and investing at the early stages in firms at the razor’s edge of Artificial Intelligence in medical technology.” Carlson’s company has assisted the expansion or sale of some 400 companies in a wide variety of market segments.
“The investment group has already seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies,” concluded Carlson.
“The investment firm’s distinguished Managing Partners’ combined credentials span venture capital investment expertise. This includes domain expertise in radiology covering a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead the formation of a selected group of physician and non-physician investors plus providing groundbreaking leadership in early stage company investments in the AI/Imaging/Radiology sector.”
For detailed information go to:
PRESS CONTACT INFORMATION:
ProNova Partners, Inc.
719 501 0004
NEWS SOURCE: ProNova Partners
This press release was issued on behalf of the news source (ProNova Partners) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: 82289 APDF-R8.6
&Copy; 2022 Send2Press®, a press release and e-marketing service of NEOTROPE®, Calif., USA.
To view the original version, visit:
Disclaimer: This press release content was not created by the Associated Press (AP).